AllerPops Reduce Nasal Symptoms in Adult Volunteers With Allergic Rhinitis

Clinical trial NCT05956691 · COMPLETED

Trial details

NCT number: NCT05956691
Sponsor: AllerPops Corp
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2022-04-05
Primary completion: 2022-09-05
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.